SAN DIEGO and AUSTIN, Texas, Aug. 16 /PRNewswire/ -- DJO Incorporated (NYSE: DJO), a global provider of products and services that promote musculoskeletal and vascular health, today reported that on August 9, 2007, the U.S. Federal Trade Commission ("FTC") granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for the proposed acquisition of DJO by an affiliate of ReAble Therapeutics, Inc. ("ReAble").
On July 16, 2007, DJO announced that it had entered into an agreement and plan of merger under which an affiliate of ReAble will acquire all outstanding shares of DJO's common stock for a cash payment of $50.25 per share. An affiliate of The Blackstone Group ("Blackstone") is the controlling shareholder of ReAble. On July 27, 2007, DJO and Blackstone submitted pre-merger notification and report forms with the FTC and the United States Department of Justice, Antitrust Division. The granting of early termination of the waiting period means the proposed acquisition has cleared U.S. antitrust review, but remains subject to satisfaction of several other conditions, including approval of the transaction by DJO's stockholders and the expiration or termination of the waiting period under the German Act Against Restraints of Competition.
Additional Information and Where to Find It
In connection with the proposed transaction, DJO intends to file a
proxy statement with the Securities and Exchange Commission (the "SEC").
STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (AND ALL AMENDMENTS AND
SUPPLEMENTS TO IT) AND OTHER MATERIALS THAT THE COMPANY MAY FILE WITH THE
SEC IN THEIR ENTIRETY WHEN SUCH MATERIALS BECOME AVAILABLE, BECAUSE THE
|SOURCE ReAble Therapeutics Inc.|
Copyright©2007 PR Newswire.